Orange Book product · Brand (NDA)
LEVITRA
VARDENAFIL HYDROCHLORIDE
At a glance
Aug 19, 2003
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 19, 2003
23 yr 2 mo ago
Today
Patent 8273876 expires
Listed method-of-use patent (U-1288) expiration.
Jul 23, 2027
in 1 yr 1 mo
Pharmaceutical detail
Active ingredient
VARDENAFIL HYDROCHLORIDE
Strength
EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 021400
Product number
003
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2010STAXYNBrand (NDA)
NDA 200179 · BAYER HLTHCARE
- 2020VARDENAFIL HYDROCHLORIDEGeneric (ANDA)
ANDA 214031 · ALEMBIC
- 2020VARDENAFIL HYDROCHLORIDEGeneric (ANDA)
ANDA 205988 · MACLEODS PHARMS LTD
- 2019VARDENAFIL HYDROCHLORIDEGeneric (ANDA)
ANDA 204632 · MACLEODS PHARMS LTD
- 2018VARDENAFIL HYDROCHLORIDEGeneric (ANDA)
ANDA 208324 · ALEMBIC
- 2018VARDENAFIL HYDROCHLORIDEGeneric (ANDA)
ANDA 209057 · CROSSMEDIKA SA
- 2018VARDENAFIL HYDROCHLORIDEGeneric (ANDA)
ANDA 210738 · STEVENS J
- 2018VARDENAFIL HYDROCHLORIDEGeneric (ANDA)
ANDA 208960 · ZYDUS PHARMS
- 2012VARDENAFIL HYDROCHLORIDEGeneric (ANDA)
ANDA 091347 · TEVA PHARMS
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8273876 | Jul 23, 2027 | in 1 yr 1 mo | U-1288 |

